President-elect Donald Trump has put forward a formal pick for the top spot at the U.S. Food and Drug Administration. As ...
For many biopharmas, it takes years of hard work to transition from being a clinical-stage drugmaker to a commercial one.
While Johnson & Johnson hopes to soon resolve more than 60,000 talc lawsuits with an $8 billion bankruptcy settlement in the ...
For Big Pharma, recent headlines out of China suggest multinational drugmakers are facing their share of challenges in the ...
New York-based health comms agency Calcium+Company is living up to its name, strengthening the bones of its business with the ...
While president-elect Donald Trump has already made his leadership picks for the Department of Health and Human Services (HHS ...
As the biopharma industry braces for a second term under President-elect Donald Trump, speculation is swirling around the ...
Few pharmaceutical products have taken the market by storm like Roche’s Vabysmo. | Interim results from a late-stage trial of ...
The new drug, Jazz Pharmaceuticals’ zanidatamab, has won an FDA accelerated approval for adults with previously treated ...
As he introduced Novartis’ meet-the-management event Thursday in London, CEO Vas Narasimhan hammered home Novartis’ status as ...
Johnson & Johnson and Merck are laying off workers in China, according to a story from Bloomberg which cites reports from ...
Roche's spinal muscular atrophy (SMA) medicine Evrysdi only gained its FDA approval in 2020, but generics companies are ...